Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uttam C Banerjee

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Archiv Der Pharmazie|May 9, 2018
Anticancer activity of dihydropyrazolo[1,5-c]quinazolines against rat C6 glioma cells via inhibition of topoisomerase IIGagandeep Kaur, Ravi P Cholia, Gaurav Joshi, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|February 6, 2021
Co-administration of zinc phthalocyanine and quercetin via hybrid nanoparticles for augmented photodynamic therapyNeeraj S Thakur, Narattam Mandal, Gopal Patel, et al.
ACS Medicinal Chemistry Letters|May 6, 2015
Switch in Site of Inhibition: A Strategy for Structure-Based Discovery of Human Topoisomerase IIα Catalytic InhibitorsAshish T Baviskar, Suyog M Amrutkar, Neha Trivedi, et al.
Journal of Medicinal Chemistry|June 8, 2011
N-fused imidazoles as novel anticancer agents that inhibit catalytic activity of topoisomerase IIα and induce apoptosis in G1/S phaseAshish T Baviskar, Chetna Madaan, Ranjan Preet, et al.
Bioorganic & Medicinal Chemistry|August 25, 2011
N-(1,3-Diaryl-3-oxopropyl)amides as a new template for xanthine oxidase inhibitorsKunal Nepali, Amit Agarwal, Sameer Sapra, et al.
Bioorganic & Medicinal Chemistry Letters|July 25, 2021
Exploration of Benzo[b]carbazole-6,11-diones as anticancer agents: Synthesis and studies of hTopoIIα inhibition and apoptotic effectsShailendra Sisodiya, Subarno Paul, Hiteshkumar Chaudhary, et al.
Bioorganic & Medicinal Chemistry|August 8, 2013
Synthesis of imine-pyrazolopyrimidinones and their mechanistic interventions on anticancer activityAshish T Baviskar, Uttam C Banerjee, Mukesh Gupta, et al.
Bioorganic & Medicinal Chemistry Letters|January 17, 2013
Indenoindolone derivatives as topoisomerase II-inhibiting anticancer agentsManeesh Kashyap, Somnath Kandekar, Ashish T Baviskar, et al.
European Journal of Medicinal Chemistry|August 25, 2019
Cyclic enaminone as new chemotype for selective cyclooxygenase-2 inhibitory, anti-inflammatory, and analgesic activitiesRaj Kumar, Nirjhar Saha, Priyank Purohit, et al.
Bioorganic & Medicinal Chemistry|March 1, 2011
A rational approach for the design and synthesis of 1-acetyl-3,5-diaryl-4,5-dihydro(1H)pyrazoles as a new class of potential non-purine xanthine oxidase inhibitorsKunal Nepali, Gurinderdeep Singh, Anil Turan, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Archiv Der Pharmazie|May 9, 2018
Anticancer activity of dihydropyrazolo[1,5-c]quinazolines against rat C6 glioma cells via inhibition of topoisomerase IIGagandeep Kaur, Ravi P Cholia, Gaurav Joshi, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|February 6, 2021
Co-administration of zinc phthalocyanine and quercetin via hybrid nanoparticles for augmented photodynamic therapyNeeraj S Thakur, Narattam Mandal, Gopal Patel, et al.
ACS Medicinal Chemistry Letters|May 6, 2015
Switch in Site of Inhibition: A Strategy for Structure-Based Discovery of Human Topoisomerase IIα Catalytic InhibitorsAshish T Baviskar, Suyog M Amrutkar, Neha Trivedi, et al.
Journal of Medicinal Chemistry|June 8, 2011
N-fused imidazoles as novel anticancer agents that inhibit catalytic activity of topoisomerase IIα and induce apoptosis in G1/S phaseAshish T Baviskar, Chetna Madaan, Ranjan Preet, et al.
Bioorganic & Medicinal Chemistry|August 25, 2011
N-(1,3-Diaryl-3-oxopropyl)amides as a new template for xanthine oxidase inhibitorsKunal Nepali, Amit Agarwal, Sameer Sapra, et al.
Bioorganic & Medicinal Chemistry Letters|July 25, 2021
Exploration of Benzo[b]carbazole-6,11-diones as anticancer agents: Synthesis and studies of hTopoIIα inhibition and apoptotic effectsShailendra Sisodiya, Subarno Paul, Hiteshkumar Chaudhary, et al.
Bioorganic & Medicinal Chemistry|August 8, 2013
Synthesis of imine-pyrazolopyrimidinones and their mechanistic interventions on anticancer activityAshish T Baviskar, Uttam C Banerjee, Mukesh Gupta, et al.
Bioorganic & Medicinal Chemistry Letters|January 17, 2013
Indenoindolone derivatives as topoisomerase II-inhibiting anticancer agentsManeesh Kashyap, Somnath Kandekar, Ashish T Baviskar, et al.
European Journal of Medicinal Chemistry|August 25, 2019
Cyclic enaminone as new chemotype for selective cyclooxygenase-2 inhibitory, anti-inflammatory, and analgesic activitiesRaj Kumar, Nirjhar Saha, Priyank Purohit, et al.
Bioorganic & Medicinal Chemistry|March 1, 2011
A rational approach for the design and synthesis of 1-acetyl-3,5-diaryl-4,5-dihydro(1H)pyrazoles as a new class of potential non-purine xanthine oxidase inhibitorsKunal Nepali, Gurinderdeep Singh, Anil Turan, et al.
Pageof 5